| 1 |
2018 |
Fluorinated Gold Nanoparticles for Nanostructure Imaging Mass Spectrometry. |
f-AuNPs |
| 2 |
2018 |
Rapid characterization of the activities of lignin-modifying enzymes based on nanostructure-initiator mass spectrometry (NIMS). |
LMEs, MnP |
| 3 |
2017 |
Morphology-Driven Control of Metabolite Selectivity Using Nanostructure-Initiator Mass Spectrometry. |
--- |
| 4 |
2017 |
On-chip integration of droplet microfluidics and nanostructure-initiator mass spectrometry for enzyme screening. |
--- |
| 5 |
2016 |
Application of Black Silicon for Nanostructure-Initiator Mass Spectrometry. |
HF, ICP |
| 6 |
2015 |
Comparison of the performance of different silicon-based SALDI substrates for illicit drug detection. |
DIOS, SALDI-MS |
| 7 |
2015 |
Development of a High Throughput Platform for Screening Glycoside Hydrolases Based on Oxime-NIMS. |
GH |
| 8 |
2015 |
Multifunctional cellulase catalysis targeted by fusion to different carbohydrate-binding modules. |
CBMs |
| 9 |
2015 |
Nanostructure imaging mass spectrometry: the role of fluorocarbons in metabolite analysis and yoctomole level sensitivity. |
--- |
| 10 |
2015 |
Nanostructure-initiator mass spectrometry (NIMS) for molecular mapping of animal tissues. |
--- |
| 11 |
2015 |
Silver Coating for High-Mass-Accuracy Imaging Mass Spectrometry of Fingerprints on Nanostructured Silicon. |
PSi, TOF |
| 12 |
2015 |
Use of Nanostructure-Initiator Mass Spectrometry to Deduce Selectivity of Reaction in Glycoside Hydrolases. |
--- |
| 13 |
2014 |
Metabolic imaging using nanostructure-initiator mass spectrometry (NIMS). |
--- |
| 14 |
2014 |
Phylogenomically guided identification of industrially relevant GH1 beta-glucosidases through DNA synthesis and nanostructure-initiator mass spectrometry. |
--- |
| 15 |
2014 |
Rapid kinetic characterization of glycosyl hydrolases based on oxime derivatization and nanostructure-initiator mass spectrometry (NIMS). |
GHs |
| 16 |
2013 |
"Replica-extraction-transfer" nanostructure-initiator mass spectrometry imaging of acoustically printed bacteria. |
REX |
| 17 |
2013 |
Assays using a NIMS chip: loosely bound but highly selective. |
PKA |
| 18 |
2013 |
Comparison of NIMS and MALDI platforms for neuropeptide and lipid mass spectrometric imaging in C. borealis brain tissue. |
MALDI, MSI |
| 19 |
2013 |
High throughput nanostructure-initiator mass spectrometry screening of microbial growth conditions for maximal beta-glucosidase production. |
MCC |
| 20 |
2013 |
Laser desorption/ionization mediated by bionanostructures from microalgae. |
DIOS, LDI-MS, MALDI |
| 21 |
2013 |
Monitoring metabolic responses to chemotherapy in single cells and tumors using nanostructure-initiator mass spectrometry (NIMS) imaging. |
FLT |
| 22 |
2013 |
On-chip enrichment and analysis of peptide subsets using a maleimide-functionalized fluorous affinity biochip and nanostructure initiator mass spectrometry. |
MALDI, MS, PSi |
| 23 |
2013 |
Towards understanding region-specificity of triplet repeat diseases: coupled immunohistology and mass spectrometry imaging. |
HD |
| 24 |
2012 |
Acoustic deposition with NIMS as a high-throughput enzyme activity assay. |
MS |
| 25 |
2012 |
Encoding substrates with mass tags to resolve stereospecific reactions using Nimzyme. |
GC/MS |
| 26 |
2012 |
Nanostructure Initiator Mass Spectrometry for tissue imaging in metabolomics: future prospects and perspectives. |
--- |
| 27 |
2012 |
Resolving brain regions using nanostructure initiator mass spectrometry imaging of phospholipids. |
--- |
| 28 |
2012 |
Semitransparent nanostructured films for imaging mass spectrometry and optical microscopy. |
--- |
| 29 |
2011 |
An Interview with Matthew P. Greving, PhD. Interview by Vicki Glaser. |
MALDI, MS |
| 30 |
2011 |
Multivariate analysis of a 3D mass spectral image for examining tissue heterogeneity. |
--- |
| 31 |
2011 |
Nanostructure-initiator mass spectrometry metabolite analysis and imaging. |
--- |
| 32 |
2010 |
Detection of carbohydrates and steroids by cation-enhanced nanostructure-initiator mass spectrometry (NIMS) for biofluid analysis and tissue imaging. |
--- |
| 33 |
2010 |
Nanostructure-initiator mass spectrometry (NIMS) imaging of brain cholesterol metabolites in Smith-Lemli-Opitz syndrome. |
7-DHC, DHCR7, SLOS |
| 34 |
2010 |
Rapid screening of fatty acids using nanostructure-initiator mass spectrometry. |
--- |
| 35 |
2009 |
Nanostructure initiator mass spectrometry: tissue imaging and direct biofluid analysis. |
--- |
| 36 |
2008 |
A nanostructure-initiator mass spectrometry-based enzyme activity assay. |
--- |
| 37 |
2008 |
Nanostructure-initiator mass spectrometry: a protocol for preparing and applying NIMS surfaces for high-sensitivity mass analysis. |
--- |
| 38 |
2007 |
Clathrate nanostructures for mass spectrometry. |
MALDI |
A Search Service for Abbreviation / Long Form
